REYATAZ

Welcome to the Brand page for “REYATAZ”, which is offered here for In the statement, column 1 lines 6, 7, 8, 9, and 10 and prevention of cardiovascular diseases central nervous system diseases and disorders stroke cancer inflammation and inflammatory diseases respiratory and should be deleted. in the statement, column 2 lines 1 and 2, auto-immune diseases, antibiotics should be deleted.;pharmaceutical preparations for the treatment [ and prevention ] of [ cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and ] infectious diseases [, auto-immune diseases, antibiotics ];.

Its status is currently believed to be active. Its class is unavailable. “REYATAZ” is believed to be currently owned by “BRISTOL-MYERS SQUIBB COMPANY”.